Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pluristem Therapeutics Inc (NASDAQ:PSTI)

1.58
Delayed Data
As of May 27
 +0.01 / +0.64%
Today’s Change
0.71
Today|||52-Week Range
2.84
+39.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues716.0K679.0K379.0K379.0K
 
 
 
 
 
Cost of Goods Sold--20.0K11.0K13.0K
 
 
 
 
Depreciation And Amortization435.0K1.0M1.9M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income---374.0K-1.5M-1.7M
 
 
 
 
General Expenses15.3M21.8M25.8M23.6M
 
 
 
 
 
Research And Development9.2M17.2M19.5M17.2M
 
 
 
 
 
Total Operating Expenses15.7M22.9M27.7M25.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.0M-22.2M-27.3M-25.3M
 
 
 
 
 
Extraordinary Credit0.00140.0K--664.0K
 
 
 
Extraordinary Charge-317.0K0.00-617.0K0.00
 
 
 
Interest Expense On Debt12.0K29.0K--37.0K
 
 
 
 
Other Expenses-9.0K691.0K755.0K-149.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.8M-21.2M-26.9M-24.7M
 
 
 
 
 
Net Income-14.8M-21.2M-26.9M-24.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.0M55.5M63.5M70.3M
 
 
 
 
 
Shares To Calculate EPS Diluted44.0M55.5M63.5M70.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.34-$0.38-$0.42-$0.35
 
 
 
 
 
EPS Diluted-$0.34-$0.38-$0.42-$0.35